[Treatment motivation in patients with chronic cardiorenal syndrome]

E V Efremova1, A M Shutov1, E O Borodulina1

  • 1Institute of Medicine, Ecology, and Physical Education, Ulyanovsk State University, Ministry of Health of Russia, Ulyanovsk, Russia.

Insights

Patients with chronic cardiorenal syndrome (CRS) show low treatment motivation. Co-existing chronic kidney disease (CKD) worsens heart failure (CHF) and psychological well-being, impacting adherence to therapies.

Area of Science:

  • Cardiology
  • Nephrology
  • Psychology

Context:

  • Chronic heart failure (CHF) management is complex.
  • Concurrent chronic kidney disease (CKD) in CHF patients, termed cardiorenal syndrome (CRS), presents unique challenges.
  • Understanding patient motivation is crucial for effective treatment adherence.

Purpose:

  • To investigate treatment motivation in patients with CHF.
  • To compare motivation levels between patients with CHF alone and those with CHF and concurrent CKD (CRS).
  • To identify psychological factors influencing treatment motivation in CRS patients.

Summary:

  • A study of 203 patients with CHF, including 89 with concurrent CKD (CRS), revealed inadequate treatment motivation in 84.7% of all CHF patients.
  • Patients with CRS exhibited higher anxiety and maladaptive disease attitudes compared to those with CHF alone.
  • Low motivation in CRS patients was linked to euphoric attitudes towards their disease, while satisfactory motivation correlated with emotive character accentuation.

Impact:

  • CKD significantly worsens the clinical course of CHF and negatively impacts patient psychological functioning.
  • CRS patients demonstrate a low motivation for both drug and non-drug treatments.
  • Findings necessitate tailored management strategies for CRS patients to improve treatment adherence and outcomes.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
533
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
595
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
581
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
508
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K